High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.
High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.
复制标题
DOI:
10.1086/656742
复制
发表时间:
2010-11-15
期刊:
影响因子:
--
通讯作者:
Pier GB
中科院分区:
文献类型:
--
作者:
Hermos CR;Yoong P;Pier GB
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) expressing Panton-Valentine Leukocidin (PVL) cause severe skin and soft tissue infections (SSTI), necrotizing pneumonia and other invasive infections. PVL toxin has been implicated as a virulence factor and antibody to a component of this toxin is under investigation as a vaccine candidate. The role of PVL in pathogenesis remains controversial and it is unknown if human serum antibody to PVL modulates infection. We determined antibody levels to PVL in sera from children aged 0-18 years presenting with PCR-confirmed PVL-positive MRSA SSTI with or without prior MRSA infection or SSTI, PVL-positive MRSA invasive infections, PVL-negative MRSA infections and uninfected controls. We also measured antibody-mediated neutralization of PVL-induced lysis of human polymorphonuclear cells. Antibody to PVL was present in healthy children reaching adult levels by 4-6 years with a nadir at 4-6 months likely due to loss of maternal antibody. Children with a primary PVL-positive MRSA infection had moderate levels of antibody to PVL that increased following infection. Children with prior MRSA or SSTI infections had high levels of antibody to PVL at the onset of infection. There was no increase in antibody to PVL in this populations’ sera after the onset of infection. Sera from children with PVL-positive MRSA SSTIs, particularly those with prior MRSA or SSTI, and convalescent sera from children with invasive PVL-positive MRSA infection, potently inhibited PVL-induced lysis of PMNs. Neutralizing antibody to PVL does not protect children against primary or recurrent CA-MRSA SSTI.
登录
查看更多内容
影响因子:
9.4
作者:
McClure, JA;Conly, JM;Zhang, KY
通讯作者:
Zhang, KY
影响因子:
168.9
作者:
DeLeo, Frank R.;Otto, Michael;Kreiswirth, Barry N.;Chambers, Henry F.
通讯作者:
Chambers, Henry F.
影响因子:
158.5
作者:
Miller, LG;Perdreau-Remington, F;Spellberg, B
通讯作者:
Spellberg, B
影响因子:
11.8
作者:
Francis, JS;Doherty, MC;Bartlett, JG
通讯作者:
Bartlett, JG
影响因子:
7.5
作者:
JULANDER, IG;GRANSTROM, M;MOLLBY, R
通讯作者:
MOLLBY, R